Nutaria is Pioneering Brain-Targeted Therapies for Parkinson's Disease
Our latest research has shown that caffeine-coated nanoparticles can effectively penetrate human neuronal cells (SH-SY5Y and U-87 cell lines), delivering active antioxidants directly. This targeted coating technology allows significant cellular uptake, unlike other nanoparticles that fail to penetrate these cells effectively. This breakthrough underscores our commitment to advancing drug delivery technologies in neurological conditions like Parkinson's disease.
Our groundbreaking solution was inspired by the work of Heiko Braak from Goethe University in Germany, who discovered that Parkinson's disease evolves from peripheral nerves, beginning with the olfactory nerve. From there, the disease progresses to intoxicate nearby brain regions. Notably, olfactory damage (anosmia) is one of the earliest symptoms of Parkinson's disease. Based on this understanding, we have strategically designed a drug that targets the olfactory route as a primary pathway for treatment. This innovative approach aims to intercept and potentially alter the disease's progression from its onset, offering a promising new avenue for early Parkinson's disease intervention.
Global Impact
With 10 Million people who have Parkinson's Disease worldwide and a 6 Billion USD global drug market, Nutaria's solutions are the next big thing in the global fight against Parkinson's and related disorders.
Products & Pipline
Nutaria is rapidly progressing to a first-in-class nasal spray solution for newly diagnosed and early Parkinson's Disease. Preclinical work is progressing rapidly, and clinical trials are expected in 2027.
Become an investor
Now is the time to invest in a product that will change the world of people with Parkinson's.
With six million people worldwide grappling with Parkinson's disease and a 6 billion USD global drug market, both projected to rapidly grow by 2030, the landscape is ripe for impactful solutions. Coupled with increasing life expectancy, investing in our products aligns strategically with the pressing demand for effective interventions in the face of this escalating public health challenge.
Collaborative Partners
Nutaria is proud to present part of our collaborating partners, all joining us in the journey to achieve our innovative vision
*Collaboration with Iff was achieved via the Innovation Laboratory Funding track by the Israeli Innovation Authority.